# CytoPherx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cytopherx

- Industry: Medical Devices & Equipment
- Headquarters: Ann Arbor, US
- Website: www.cytopherx.com
- Total disclosed funding: $42M
- Latest round: Series C (Jan 4, 2012)
- Investors on record: 13

## About

Founded in 2007 and based in Michigan, US, CytoPherx, Inc., is a clinical stage medical device company, that develops cytopheresis systems for addressing diseases and conditions related to inflammation.

## Funding rounds

- Series C, Jan 4, 2012, $34M — Apjohn Ventures, Dow Chemical Company Pension Fund, ONSET Ventures, Aphelion Capital, Early Stage Partners, Union Carbide Employees' Pension Plan, Emergent Medical Ventures, Charter Oak Equity, Capital Midwest Fund, North Coast Technology Investors, Kaiser Permanente Ventures, Lurie Investments
- Series B, Jun 17, 2010, $7.5M — Apjohn Ventures, Diamond Capital, Lurie Investments

## Investors

- Apjohn Ventures (https://capitalatlas.ai/funds/apjohn-ventures) — Series B, Series C
- Diamond Capital — Series B
- Lurie Investments — Series B, Series C
- Dow Chemical Company Pension Fund — Series C
- ONSET Ventures (https://capitalatlas.ai/funds/onset-ventures) — Series C
- Aphelion Capital (https://capitalatlas.ai/funds/aphelion-capital) — Series C
- Early Stage Partners (https://capitalatlas.ai/funds/early-stage-partners) — Series C
- Union Carbide Employees' Pension Plan — Series C
- Emergent Medical Ventures (https://capitalatlas.ai/funds/emergent-medical-ventures) — Series C
- Charter Oak Equity (https://capitalatlas.ai/funds/charter-oak-equity) — Series C
- Capital Midwest Fund (https://capitalatlas.ai/funds/capital-midwest-fund) — Series C
- North Coast Technology Investors (https://capitalatlas.ai/funds/north-coast-technology-investors) — Series C
- Kaiser Permanente Ventures (https://capitalatlas.ai/funds/kaiser-permanente-ventures) — Series C